One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Active Implantable Medical Devices Market

[ 英語タイトル ] Active Implantable Medical Devices Market by Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) - Global Forecast to 2022


Product Code : MNMHC00108116
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

The active implantable medical devices market is estimated to grow at a CAGR of 7.8% from 2017 to 2022, to reach USD 26.75 billion by 2022 from USD 18.42 billion in 2017. The growth of this market is mainly attributed to the rising aging population, increasing prevalence of cardiovascular and neurological diseases, investments and funds to develop technologically advanced products, expanded applications of neurostimulators, and favorable reimbursement scenario for ENT procedures in developed countries. However, unfavorable healthcare reforms in the U.S., issues related to the use of implantable medical devices, and the high cost of cardiac and neurostimulators implantable devices may hinder the growth of this market to a certain extent during the forecast period. Growth opportunities in the emerging markets and the development of subcutaneous implantable cardioverter defibrillators offer significant growth opportunities in this market.
In this report, the active implantable medical devices market is segmented on the basis of product and region. On the basis of product, the market is segmented into implantable cardioverter defibrillators, implantable cardiac pacemakers, implantable heart monitors/insertable loop recorders, ventricular assist devices, neurostimulators, and implantable hearing devices. The Implantable hearing devices segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment is primarily attributed to the increasing prevalence of hearing loss across the globe and growing ENT procedures due to favorable reimbursement policies in the developed countries.
Geographically, North America commanded a major share of the active implantable medical devices market in 2016. Factors such as growth in geriatric population, increasing prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increasing development of innovative and technologically advanced products, and increasing healthcare expenditure in the region are contributing to the large share of North America. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the rising geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies to develop advanced products, and less stringent regulations in this region.
Some of the prominent players in the implantable cardiovascular devices market include Medtronic plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), and LivaNova PLC (U.K.); whereas, Cochlear Limited (Australia), MED-EL (Austria), Sonova Holding AG (Switzerland), William Demant Holding A/S (Denmark), and Nurotron Biotechnology Co., Ltd. (China) are the key players in the implantable hearing devices market.
Research Coverage:
The report analyzes the various type of active implantable medical devices provided by medical device manufacturers across the globe. It aims at estimating the market size and future growth potential of the active implantable medical devices market for different products and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product portfolio, recent developments, and key market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.
The report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the active implantable medical devices market. The report analyzes the active implantable medical devices market by product and region
 Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the active implantable medical devices market
 Market Development: Comprehensive information about the lucrative emerging markets by product and region
 Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the active implantable medical devices market
 Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and manufacturing capabilities of leading players in the active implantable medical devices market

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH APPROACH 20
2.1.1 SECONDARY SOURCES 21
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 22
2.1.2.2 Key industry insights 23
2.2 MARKET SIZE ESTIMATION 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.4 MARKET SHARE ESTIMATION 27
2.5 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 31
4.1 ACTIVE IMPLANTABLE MEDICAL DEVICES: MARKET SNAPSHOT 31
4.2 EUROPE: ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT 32
4.3 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 33
4.4 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: GEOGRAPHIC MIX 34
4.5 ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES/REGIONS 34

5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 36
5.2.1 MARKET DRIVERS 37
5.2.1.1 Increasing burden of cardiovascular diseases 37
5.2.1.2 Rising prevalence of neurological disorders 38
5.2.1.3 Investments and funds to develop technologically advanced products 39
5.2.1.4 Expanded applications of neurostimulators 40
5.2.1.5 Favorable reimbursement scenario for ent procedures in developed countries 40
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Unfavorable healthcare reforms in the U.S. 41
5.2.2.2 Issues related to the use of implantable medical devices 41
5.2.2.3 High cost of implants and an unfavorable reimbursement scenario 42
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Emerging markets offer significant growth opportunities 42
5.2.3.2 Development of subcutaneous implantable cardioverter defibrillators (S-ICDs) 43
5.2.4 MARKET CHALLENGES 44
5.2.4.1 Increasing pricing pressure on market players 44
5.2.4.2 Dearth of skilled professionals 45
6 INDUSTRY INSIGHTS 46
6.1 INTRODUCTION 46
6.2 KEY INDUSTRY TRENDS 46
6.2.1 INCREASING MARKET CONSOLIDATION 47
6.2.2 DEVELOPMENT OF INNOVATIVE, EASY-TO-USE IMPLANTABLE CARDIOVASCULAR PRODUCTS WITH INCREASED LONGEVITY 48
6.2.3 DEVELOPMENT OF TECHNOLOGICALLY ADVANCED IMPLANTABLE HEARING DEVICES AND EXPANSION OF DISTRIBUTION CHANNEL FOR HEARING IMPLANTS 48
6.3 REGULATORY ANALYSIS 49
6.3.1 NORTH AMERICA 49
6.3.1.1 U.S. 49
6.3.1.2 Canada 51
6.3.2 EUROPE 51
6.3.3 ASIA-PACIFIC 52
6.3.3.1 Japan 52
6.3.3.2 China 53
6.3.3.3 India 54
6.3.4 REST OF THE WORLD 54

7 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT 55
7.1 INTRODUCTION 56
7.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 58
7.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 60
7.2.1.1 Biventricular implantable cardioverter defibrillators (ICDs)/cardiac resynchronization therapy defibrillators (CRT-Ds) 62
7.2.1.2 Dual-chamber implantable cardioverter defibrillators 63
7.2.1.3 Single-chamber implantable cardioverter defibrillators 65
7.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 66
7.3 IMPLANTABLE CARDIAC PACEMAKERS 68
7.4 VENTRICULAR ASSIST DEVICES 71
7.5 IMPLANTABLE HEART MONITORS/INSERTABLE LOOP RECORDERS 72
7.6 NEUROSTIMULATORS 74
7.6.1 SPINAL CORD STIMULATORS 75
7.6.2 DEEP BRAIN STIMULATORS 77
7.6.3 SACRAL NERVE STIMULATORS 78
7.6.4 VAGUS NERVE STIMULATORS 79
7.6.5 GASTRIC ELECTRICAL STIMULATORS 81
7.7 IMPLANTABLE HEARING DEVICES 82
7.7.1 ACTIVE HEARING IMPLANTS 84
7.7.2 PASSIVE HEARING IMPLANTS 86
8 GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION 87
8.1 INTRODUCTION 88
8.2 NORTH AMERICA 89
8.2.1 U.S. 94
8.2.2 CANADA 98
8.3 EUROPE 102
8.3.1 GERMANY 106
8.3.2 U.K. 110
8.3.3 FRANCE 114
8.3.4 ITALY 118
8.3.5 SPAIN 122
8.3.6 REST OF EUROPE (ROE) 126
8.4 ASIA-PACIFIC 130
8.4.1 JAPAN 136
8.4.2 CHINA 139
8.4.3 INDIA 142
8.4.4 REST OF ASIA-PACIFIC (RO-APAC) 145
8.5 LATIN AMERICA 149
8.6 MIDDLE EAST AND AFRICA 152
9 COMPETITIVE LANDSCAPE 156
9.1 OVERVIEW 156
9.2 MARKET SHARE ANALYSIS 158
9.3 COMPETITIVE SITUATIONS AND TRENDS 162
9.3.1 PRODUCT LAUNCHES 163
9.3.2 MERGERS & ACQUISITIONS 164
9.3.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 165
9.3.4 EXPANSIONS 166
10 COMPANY PROFILES 167
10.1 INTRODUCTION 167
(OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*
10.2 ABBOTT LABORATORIES 169
10.3 MEDTRONIC PLC 171
10.4 BOSTON SCIENTIFIC CORPORATION 174
10.5 BIOTRONIK SE & CO., KG 177
10.6 LIVANOVA PLC 179
10.7 WILLIAM DEMANT HOLDING A/S 182
10.8 COCHLEAR LIMITED 184
10.9 SONOVA HOLDING AG 186
10.10 MED-EL 188
10.11 NUROTRON BIOTECHNOLOGY CO. LTD. 189
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
11 APPENDIX 190
11.1 INSIGHTS OF INDUSTRY EXPERTS 190
11.2 DISCUSSION GUIDE 191
11.3 OTHER DEVELOPMENTS 194
11.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 198
11.5 AVAILABLE CUSTOMIZATIONS 200
11.6 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 201
11.7 RELATED REPORTS 203
11.8 AUTHOR DETAILS 204

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+